Trending NewsTrending NewsNASDAQ:ATEC Alphatec (ATEC) Stock Price, News & Analysis $13.77 +3.19 (+30.15%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$13.72 -0.05 (-0.36%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Alphatec Stock (NASDAQ:ATEC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Alphatec alerts:Sign Up Key Stats Today's Range$11.66▼$13.8950-Day Range$10.31▼$13.7752-Week Range$4.88▼$13.89Volume13.00 million shsAverage Volume1.44 million shsMarket Capitalization$2.01 billionP/E RatioN/ADividend YieldN/APrice Target$18.33Consensus RatingBuy Company Overview Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California. Read More Alphatec Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks86th Percentile Overall ScoreATEC MarketRank™: Alphatec scored higher than 86% of companies evaluated by MarketBeat, and ranked 136th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAlphatec has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlphatec has only been the subject of 2 research reports in the past 90 days.Read more about Alphatec's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Alphatec are expected to grow in the coming year, from ($1.08) to ($0.65) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alphatec is -12.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alphatec is -12.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.93% of the outstanding shares of Alphatec have been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in Alphatec has recently decreased by 2.68%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAlphatec does not currently pay a dividend.Dividend GrowthAlphatec does not have a long track record of dividend growth. Sustainability and ESG3.3 / 5Environmental Score-1.67 Percentage of Shares Shorted8.93% of the outstanding shares of Alphatec have been sold short.Short Interest Ratio / Days to CoverAlphatec has a short interest ratio ("days to cover") of 7.9.Change versus previous monthShort interest in Alphatec has recently decreased by 2.68%, indicating that investor sentiment is improving. News and Social Media3.1 / 5News Sentiment0.56 News SentimentAlphatec has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Alphatec this week, compared to 6 articles on an average week.Search Interest3 people have searched for ATEC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Alphatec insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,698,956.00 in company stock.Percentage Held by Insiders20.90% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.35% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Alphatec's insider trading history. Receive ATEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter. Email Address ATEC Stock News HeadlinesInsider Selling: Alphatec Holdings, Inc. (NASDAQ:ATEC) General Counsel Sells 1,500 Shares of StockJuly 15, 2025 | insidertrades.comAlphatec (NASDAQ:ATEC) Shares Gap Up Following Strong Earnings31 minutes ago | americanbankingnews.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. | Brownstone Research (Ad)Alphatec Holdings outlines $742M revenue target for 2025 amid record EBITDA and expanding ecosystemAugust 2 at 2:42 AM | msn.comAlphatec Holdings Inc (ATEC) Q2 2025 Earnings Call Highlights: Record EBITDA and Market ...August 2 at 2:42 AM | finance.yahoo.comAlphatec (ATEC) Q2 Revenue Jumps 27%August 1 at 8:16 PM | fool.comAlphatec Holdings, Inc. (ATEC) Q2 2025 Earnings Call TranscriptAugust 1 at 11:03 AM | seekingalpha.comAlphatec Holdings, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 1 at 10:53 AM | seekingalpha.comSee More Headlines ATEC Stock Analysis - Frequently Asked Questions How have ATEC shares performed this year? Alphatec's stock was trading at $9.18 at the beginning of the year. Since then, ATEC stock has increased by 50.0% and is now trading at $13.77. How were Alphatec's earnings last quarter? Alphatec Holdings, Inc. (NASDAQ:ATEC) announced its quarterly earnings data on Thursday, July, 31st. The medical technology company reported $0.02 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.08. Alphatec's revenue was up 27.5% compared to the same quarter last year. Read the conference call transcript. Who are Alphatec's major shareholders? Top institutional investors of Alphatec include Motley Fool Wealth Management LLC (0.74%), Aberdeen Group plc (0.69%), Motley Fool Asset Management LLC (0.41%) and Congress Asset Management Co. (0.27%). Insiders that own company stock include L-5 Healthcare Partners, Llc, Patrick Miles, Craig E Hunsaker, Scott Lish, David Sponsel, Tyson Eliot Marshall, James L L Tullis, John Todd Koning, David M Demski, Paul Segal, David H Mowry, Jennifer N Pritzker and Evan Bakst. View institutional ownership trends. How do I buy shares of Alphatec? Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Alphatec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Alphatec investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Meta Platforms (META). Company Calendar Last Earnings7/31/2025Today8/02/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:ATEC CIK1350653 Webwww.atecspine.com Phone(760) 431-9286Fax800-922-1356Employees700Year Founded1990Price Target and Rating Average Price Target for Alphatec$18.33 High Price Target$21.00 Low Price Target$15.00 Potential Upside/Downside+33.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($1.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$162.12 million Net Margins-24.33% Pretax Margin-25.76% Return on Equity-1,657.19% Return on Assets-21.59% Debt Debt-to-Equity RatioN/A Current Ratio2.75 Quick Ratio1.67 Sales & Book Value Annual Sales$642.27 million Price / Sales3.13 Cash FlowN/A Price / Cash FlowN/A Book Value($0.10) per share Price / Book-137.70Miscellaneous Outstanding Shares146,173,000Free Float115,623,000Market Cap$2.01 billion OptionableOptionable Beta1.05 Social Links 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:ATEC) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alphatec Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alphatec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.